Informações de Vanda Pharmaceuticals Inc

Mais detalhes de Vanda Pharmaceuticals Inc Empresa

Vanda Pharmaceuticals Inc. is a biopharmaceutical company, which is focused on the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. The Company’s commercial portfolio is comprised of three products: HETLIOZ for the treatment of non-24-hour sleep-wake disorder (Non-24) and for the treatment of nighttime sleep disturbances in smith-magenis syndrome (SMS), Fanapt (iloperidone) for the treatment of bipolar I disorder and a long acting injectable (LAI) formulation for the treatment of schizophrenia, and PONVORY (ponesimod) for the treatment of inflammatory/autoimmune disorders, including ulcerative colitis, psoriasis, Crohn's disease, atopic dermatitis, eosinophilic esophagitis and alopecia areata. The Company also has a range of drugs in development, including Tradipitant (VLY-686), VHX-896, VSJ-110, VPO-227, VTR-297, VQW-765, VCA-894A and Type 2S (CMT2S).



Código da empresaVNDA

Nome da EmpresaVanda Pharmaceuticals Inc

Data de listagemApr 12, 2006

CEODr. Mihael Hristos Polymeropoulos, M.D.

Número de funcionários368

Tipo de títulosOrdinary Share

Fim do ano fiscalApr 12

EndereçoSuite 300E

CidadeWASHINGTON

Bolsa de valoresNASDAQ Global Market Consolidated

PaísUnited States of America

Código postal20037

Telefone12027343400

Sitehttps://www.vandapharma.com/

Código da empresaVNDA

Data de listagemApr 12, 2006

CEODr. Mihael Hristos Polymeropoulos, M.D.

Executivos da empresa Vanda Pharmaceuticals Inc



Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Mihael Hristos Polymeropoulos, M.D.

Chairman of the Board, President, Chief Executive Officer

2.34M

+0.43%

Mr. Gunther Birznieks

Senior Vice President - Business Development

411.63K

+73.26%

Mr. Kevin Patrick Moran

Chief Financial Officer, Senior Vice President, Treasurer

329.46K

+118.08%

Mr. Richard W. Dugan

Lead Independent Director

177.45K

+50.09%

Dr. Tage Honore, Ph.D.

Independent Director

123.47K

+92.19%

Ms. Anne Sempowski Ward

Independent Director

119.07K

+98.97%

Dr. Stephen Ray Mitchell, M.D.

Independent Director

97.08K

+116.43%

Mr. Timothy I. Williams

Senior Vice President, General Counsel, Secretary

--

Ms. Phaedra S. Chrousos

Independent Director

--

Mr. Joakim (Kim) Wijkstrom

Senior Vice President, Chief Marketing Officer

--

Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Mihael Hristos Polymeropoulos, M.D.

Chairman of the Board, President, Chief Executive Officer

2.34M

+0.43%

Mr. Gunther Birznieks

Senior Vice President - Business Development

411.63K

+73.26%

Mr. Kevin Patrick Moran

Chief Financial Officer, Senior Vice President, Treasurer

329.46K

+118.08%

Mr. Richard W. Dugan

Lead Independent Director

177.45K

+50.09%

Dr. Tage Honore, Ph.D.

Independent Director

123.47K

+92.19%

Ms. Anne Sempowski Ward

Independent Director

119.07K

+98.97%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Fanapt

29.29M

55.70%

Hetlioz

16.19M

30.79%

PONVORY

7.10M

13.51%

Sem dados

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Fanapt

29.29M

55.70%

Hetlioz

16.19M

30.79%

PONVORY

7.10M

13.51%

Distribuição de ações

Atualizado em: sex, 15 de ago

Investidores

Tipos de investidores

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

10.13%

The Vanguard Group, Inc.

5.99%

Renaissance Technologies LLC

5.83%

Millennium Management LLC

5.28%

Dimensional Fund Advisors, L.P.

4.38%

Outro

68.39%

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

10.13%

The Vanguard Group, Inc.

5.99%

Renaissance Technologies LLC

5.83%

Millennium Management LLC

5.28%

Dimensional Fund Advisors, L.P.

4.38%

Outro

68.39%

Tipos de investidores

Investidores

Proporção

Investment Advisor

27.57%

Investment Advisor/Hedge Fund

27.14%

Hedge Fund

19.34%

Individual Investor

7.19%

Research Firm

3.40%

Pension Fund

0.72%

Bank and Trust

0.20%

Sovereign Wealth Fund

0.19%

Venture Capital

0.05%

Outro

14.18%

Participação acionária institucional



Atualizado em: qua, 1 de out

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q3

373

46.47M

78.64%

-9.95M

2025Q2

417

50.75M

85.90%

-11.31M

2025Q1

426

48.51M

82.37%

-12.27M

2024Q4

444

46.48M

79.71%

-15.23M

2024Q3

446

47.42M

81.36%

-14.93M

2024Q2

445

46.99M

80.73%

-18.42M

2024Q1

434

53.50M

92.97%

-11.41M

2023Q4

445

55.38M

96.27%

-9.21M

2023Q3

446

56.79M

98.75%

-12.15M

2023Q2

434

60.42M

105.19%

-10.16M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

BlackRock Institutional Trust Company, N.A.

5.99M

10.13%

-31.47K

-0.52%

Jun 30, 2025

The Vanguard Group, Inc.

3.54M

5.99%

+46.84K

+1.34%

Jun 30, 2025

Renaissance Technologies LLC

3.45M

5.83%

-118.97K

-3.34%

Jun 30, 2025

Millennium Management LLC

3.12M

5.28%

+980.75K

+45.84%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

2.59M

4.38%

+46.08K

+1.81%

Jun 30, 2025

BlackRock Financial Management, Inc.

2.43M

4.12%

+286.64K

+13.35%

Jun 30, 2025

Tang Capital Management, LLC

2.35M

3.98%

--

Jun 30, 2025

Polymeropoulos (Mihael Hristos)

2.34M

3.95%

+10.00K

+0.43%

Aug 07, 2025

Acadian Asset Management LLC

1.73M

2.93%

-155.16K

-8.22%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.69M

2.86%

+78.00K

+4.83%

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: qui, 6 de nov

Nome

Proporção

Invesco NASDAQ Future Gen 200 ETF

0.51%

iShares Neuroscience and Healthcare ETF

0.49%

ALPS Medical Breakthroughs ETF

0.17%

SPDR SSGA US Small Cap Low Volatility Index ETF

0.13%

Federated Hermes MDT Small Cap Core ETF

0.1%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.05%

iShares Micro-Cap ETF

0.05%

Franklin US Small Cap Multifactor Index ETF

0.04%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

0.03%

ProShares Ultra Nasdaq Biotechnology

0.03%

Ver Mais

Invesco NASDAQ Future Gen 200 ETF

Proporção0.51%

iShares Neuroscience and Healthcare ETF

Proporção0.49%

ALPS Medical Breakthroughs ETF

Proporção0.17%

SPDR SSGA US Small Cap Low Volatility Index ETF

Proporção0.13%

Federated Hermes MDT Small Cap Core ETF

Proporção0.1%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

Proporção0.05%

iShares Micro-Cap ETF

Proporção0.05%

Franklin US Small Cap Multifactor Index ETF

Proporção0.04%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

Proporção0.03%

ProShares Ultra Nasdaq Biotechnology

Proporção0.03%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados